Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Adventrx Pharma Announces Deal With Patheon To Manufacture ANX-188 Drug Product

RELATED NEWS
Trade ANX now with 
6/26/2012 11:52 AM ET

Adventrx Pharmaceuticals Inc. (ANX: Quote) announced that it has entered into a multi-year agreement with Patheon Inc. under which Patheon will formulate, fill and finish ANX-188 drug product for use in clinical trials, including the phase 3 study of ANX-188 that Adventrx plans to initiate this year.

Click here to receive FREE breaking news email alerts for Mast Therapeutics Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks May Show A Lack Of Direction In Early Trading - U.S. Commentary
After turning in a lackluster performance throughout the previous session, stocks may continue to experience choppy trading on Tuesday. The major index futures are currently pointing to a roughly flat open for the markets.
U.K. Inflation Eases To 7-Month Low
U.K. consumer price inflation slowed more-than-expected to a seven-month low in April on falling petrol and air fares, official data revealed Tuesday. The slowdown provides relief for consumers as it raises purchasing power, while it gives more scope for the central bank to ease monetary policy.
Obama To Deliver Speech On Counterterrorism Policies, Use Of Drones
President Barack Obama reportedly plans to deliver a much-anticipated speech on Thursday outlining his administration's evolving counterterrorism policies. Multiple news sources cited a White House official as saying that Obama will address the use of drones and plans to close the detention facility at Guantanamo Bay in a speech at the National Defense University.
FREE Newsletters & Alerts
Breaking News Alerts
Daily Market Briefing
Health
Technology
Biotechnology
signup

Follow RTT
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.
[X]
Copyright © 2013 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.
Privacy   |   Feedback   |   Sitemap